Valirx plc (VAL) ORD GBP0.001
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.50p
0.51p
4.35p
£1.87 million
0.50p
0.45p
0.39p
n/a
0.00p (0.00%) Previous:
0.00p
33,323
n/a
30,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2023 | 31/12/2022 |
|---|---|---|
| Revenue (£m) | 0.01 | n/a |
| Profit before tax (£m) | (2.30) | (2.60) |
| Adjusted EPS (p): | (2.01) | (3.06) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
ValiRx terminates exclusive negotiations with TheoremRx
3 April 2025 14:58
-
ValiRx's Inaphaea inks deal with UK-based Screenin3D
3 February 2025 12:20
-
ValiRx enters evaluation and option deal with Canada's Altus
29 January 2025 11:13
-
Termination of Letter of Intent with TheoremRx
3 April 2025 07:00
-
Directorate Changes and new Advisory Board
27 March 2025 07:00
-
Director Disclosure Update
21 March 2025 11:07
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.